Podolanczuk AJ, Thomson CC, Remy-Jardin M, Richeldi L, Martinez FJ, Kolb M, Raghu G (2023) Idiopathic pulmonary fibrosis: state of the art for 2023. Eur Respir J 61(4). https://doi.org/10.1183/13993003.00957-2022

Moss BJ, Ryter SW, Rosas IO (2022) Pathogenic mechanisms underlying idiopathic pulmonary fibrosis. Annu Rev Pathol 17:515–546. https://doi.org/10.1146/annurev-pathol-042320-030240

Article  CAS  PubMed  Google Scholar 

Li M, Chen B, Zhang X, Zhuo T, Liu X (2025) Advances in novel therapeutics for idiopathic pulmonary fibrosis. Pulm Pharmacol Ther 102396. https://doi.org/10.1016/j.pupt.2025.102396

Ley B, Collard HR, King TE Jr. (2011) Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 183(4):431–440. https://doi.org/10.1164/rccm.201006-0894CI

Article  PubMed  Google Scholar 

Spagnolo P, Kropski JA, Jones MG, Lee JS, Rossi G, Karampitsakos T, Maher TM, Tzouvelekis A, Ryerson CJ (2021) Idiopathic pulmonary fibrosis: disease mechanisms and drug development. Pharmacol Ther 222:107798. https://doi.org/10.1016/j.pharmthera.2020.107798

Article  CAS  PubMed  Google Scholar 

She YX, Yu QY, Tang XX (2021) Role of interleukins in the pathogenesis of pulmonary fibrosis. Cell Death Discov 7(1):52. https://doi.org/10.1038/s41420-021-00437-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clegg DO, Reda DJ, Harris CL, Klein MA, O’Dell JR, Hooper MM, Bradley JD, Bingham CO 3rd, Weisman MH, Jackson CG, Lane NE, Cush JJ, Moreland LW, Schumacher HR Jr., Oddis CV, Wolfe F, Molitor JA, Yocum DE, Schnitzer TJ, Furst DE, Sawitzke AD, Shi H, Brandt KD, Moskowitz RW, Williams HJ (2006) Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 354(8):795–808. https://doi.org/10.1056/NEJMoa052771

Article  CAS  PubMed  Google Scholar 

Conrozier T, Lohse T (2022) Glucosamine as a treatment for osteoarthritis: what if it’s true? Front Pharmacol 13:820971. https://doi.org/10.3389/fphar.2022.820971

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma H, Li X, Sun D, Zhou T, Ley SH, Gustat J, Heianza Y, Qi L (2019) Association of habitual glucosamine use with risk of cardiovascular disease: prospective study in UK Biobank. BMJ 365:l1628. https://doi.org/10.1136/bmj.l1628

Article  PubMed  PubMed Central  Google Scholar 

Ma H, Li X, Zhou T, Sun D, Liang Z, Li Y, Heianza Y, Qi L (2020) Glucosamine use, inflammation, and genetic susceptibility, and incidence of type 2 diabetes: a prospective study in UK biobank. Diabetes Care 43(4):719–725. https://doi.org/10.2337/dc19-1836

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li G, Zhang X, Liu Y, Zhang J, Li L, Huang X, Thabane L, Lip GYH (2022) Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study. Eur Respir J 59(3). https://doi.org/10.1183/13993003.01399-2021

Zhang XR, Zhang PD, Li ZH, Yang P, Wang XM, Liu HM, Liang F, Wang JD, Sun Y, Shen D, Chen PL, Zhong WF, Huang QM, Liu D, Wang ZH, Kraus VB, Mao C (2022) Glucosamine use, smoking and risk of incident chronic obstructive pulmonary disease: a large prospective cohort study. Br J Nutr 128(4):721–732. https://doi.org/10.1017/S000711452100372X

Article  CAS  PubMed  Google Scholar 

Li ZH, Gao X, Chung VC, Zhong WF, Fu Q, Lv YB, Wang ZH, Shen D, Zhang XR, Zhang PD, Li FR, Huang QM, Chen Q, Song WQ, Wu XB, Shi XM, Kraus VB, Yang X, Mao C (2020) Associations of regular glucosamine use with all-cause and cause-specific mortality: a large prospective cohort study. Ann Rheum Dis 79(6):829–836. https://doi.org/10.1136/annrheumdis-2020-217176

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lam CS, Hua R, Loong HH, Chung VC, Cheung YT (2024) Association between fish oil and glucosamine use and mortality in patients diagnosed with cancer: the role of the Life Essential 8 score and cancer prognosis. Nutr J 23(1):124. https://doi.org/10.1186/s12937-024-01032-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xing D, Feng W, Not LG, Miller AP, Zhang Y, Chen YF, Majid-Hassan E, Chatham JC, Oparil S (2008) Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury. Am J Physiol Heart Circ Physiol 295(1):H335–342. https://doi.org/10.1152/ajpheart.01259.2007

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yao D, Xu L, Xu O, Li R, Chen M, Shen H, Zhu H, Zhang F, Yao D, Chen YF, Oparil S, Zhang Z, Gong K (2018) O-linked β-N-Acetylglucosamine modification of A20 enhances the inhibition of NF-κB (nuclear factor-κB) Activation and elicits vascular protection after acute endoluminal arterial injury. Arterioscler Thromb Vasc Biol 38(6):1309–1320. https://doi.org/10.1161/atvbaha.117.310468

Article  CAS  PubMed  Google Scholar 

Kantor ED, Lampe JW, Vaughan TL, Peters U, Rehm CD, White E (2012) Association between use of specialty dietary supplements and C-reactive protein concentrations. Am J Epidemiol 176(11):1002–1013. https://doi.org/10.1093/aje/kws186

Article  PubMed  PubMed Central  Google Scholar 

Fathimath Muneesa M, Shaikh SB, Jeena TM, Bhandary YP (2021) Inflammatory mediators in various molecular pathways involved in the development of pulmonary fibrosis. Int Immunopharmacol 96:107608. https://doi.org/10.1016/j.intimp.2021.107608

Article  CAS  PubMed  Google Scholar 

Fu C, Wang L, Cai W (2024) IL6 receptor inhibitors: exploring the therapeutic potential across multiple diseases through drug target Mendelian randomization. Front Immunol 15:1452849. https://doi.org/10.3389/fimmu.2024.1452849

Article  CAS  PubMed  PubMed Central  Google Scholar 

Allen RJ, Porte J, Braybrooke R, Flores C, Fingerlin TE, Oldham JM, Guillen-Guio B, Ma SF, Okamoto T, John AE, Obeidat M, Yang IV, Henry A, Hubbard RB, Navaratnam V, Saini G, Thompson N, Booth HL, Hart SP, Hill MR, Hirani N, Maher TM, McAnulty RJ, Millar AB, Molyneaux PL, Parfrey H, Rassl DM, Whyte MKB, Fahy WA, Marshall RP, Oballa E, Bosse Y, Nickle DC, Sin DD, Timens W, Shrine N, Sayers I, Hall IP, Noth I, Schwartz DA, Tobin MD, Wain LV, Jenkins RG (2017) Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study. Lancet Respir Med 5(11):869–880. https://doi.org/10.1016/S2213-2600(17)30387-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li ZH, Song WQ, Shen D, Zhang PD, Zhou JM, Zhang XR, Zhang YJ, Ren JJ, Chen YJ, Liu D, Zhong WF, Chen PL, Huang QM, Wang XM, Liang F, Qiu CS, Chen ZT, Li C, Mao C (2022) Habitual fish oil supplementation and incident chronic obstructive pulmonary disease: Data from a prospective cohort study. Clin Nutr 41(12):2651–2658. https://doi.org/10.1016/j.clnu.2022.10.002

Article  PubMed  Google Scholar 

Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M, Liu B, Matthews P, Ong G, Pell J, Silman A, Young A, Sprosen T, Peakman T, Collins R (2015) UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 12(3):e1001779. https://doi.org/10.1371/journal.pmed.1001779

Article  PubMed  PubMed Central  Google Scholar 

Yu K, Lv J, Qiu G, Yu C, Guo Y, Bian Z, Yang L, Chen Y, Wang C, Pan A, Liang L, Hu FB, Chen Z, Li L, Wu T, China Kadoorie Biobank S (2020) Cooking fuels and risk of all-cause and cardiopulmonary mortality in urban China: a prospective cohort study. Lancet Glob Health 8(3):e430–e439. https://doi.org/10.1016/S2214-109X(19)30525-X

Article  PubMed  PubMed Central  Google Scholar 

Bellou V, Belbasis L, Evangelou E (2021) Tobacco smoking and risk for pulmonary fibrosis: a prospective cohort study from the UK biobank. Chest 160(3):983–993. https://doi.org/10.1016/j.chest.2021.04.035

Article  PubMed  Google Scholar 

Cui F, Sun Y, Xie J, Li D, Wu M, Song L, Hu Y, Tian Y (2023) Air pollutants, genetic susceptibility and risk of incident idiopathic pulmonary fibrosis. Eur Respir J 61(2). https://doi.org/10.1183/13993003.00777-2022

Duckworth A, Gibbons MA, Allen RJ, Almond H, Beaumont RN, Wood AR, Lunnon K, Lindsay MA, Wain LV, Tyrrell J, Scotton CJ (2021) Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a mendelian randomisation study. Lancet Respir Med 9(3):285–294. https://doi.org/10.1016/S2213-2600(20)30364-7

Article  CAS  PubMed  Google Scholar 

Ma Y, Cui F, Li D, Wang J, Tang L, Xie J, Hu Y, Tian Y (2023) Lifestyle, genetic susceptibility, and the risk of idiopathic pulmonary fibrosis: a large prospective cohort study. Chest 164(4):929–938. https://doi.org/10.1016/j.chest.2023.04.008

Article  CAS  PubMed  Google Scholar 

Wang T, Duan W, Jia X, Huang X, Liu Y, Meng F, Ni C (2024) Associations of combined phenotypic ageing and genetic risk with incidence of chronic respiratory diseases in the UK Biobank: a prospective cohort study. Eur Respir J 63(2). https://doi.org/10.1183/13993003.01720-2023